Maia Biotechnology, INC. (MAIA) — 8-K Filings

All 8-K filings from Maia Biotechnology, INC.. Browse 50 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (50)

8-K Filing — Apr 8, 2026
MAIA Biotechnology Files 8-K — Mar 31, 2026 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on March 31, 2026, reporting other events and financial statements. The filing includes an exhibit (EX-99.1) and interacti
MAIA Biotechnology Files 8-K — Mar 27, 2026 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on March 27, 2026, reporting under Regulation FD and other events. The filing includes financial statements and exhibits,
MAIA Biotechnology Files 8-K: Material Agreement & Equity Sales — Dec 17, 2025 Risk: medium
On December 16, 2025, MAIA Biotechnology, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securitie
8-K Filing — Dec 11, 2025
8-K Filing — Dec 10, 2025
MAIA Biotechnology Files 8-K — Nov 21, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on November 21, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specif
MAIA Biotechnology Files 8-K — Nov 20, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on November 20, 2025, reporting other events and financial statements. The company, incorporated in Delaware, has its prin
MAIA Biotechnology Files 8-K Report — Oct 27, 2025 Risk: low
On October 27, 2025, MAIA Biotechnology, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," with no
MAIA Biotechnology Files 8-K — Oct 24, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on October 24, 2025, reporting other events and financial statements. The filing details the company's incorporation in De
MAIA Biotechnology Files 8-K — Oct 23, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on October 23, 2025, reporting events that occurred on October 19, 2025. The filing includes information related to Regula
MAIA Biotechnology Files 8-K: Material Agreement, Equity Sales — Oct 14, 2025 Risk: medium
On October 13, 2025, MAIA Biotechnology, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities
MAIA Biotechnology Files 8-K — Oct 7, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on October 7, 2025, reporting other events and financial statements. The filing does not contain specific details about th
MAIA Biotechnology Files 8-K on Key Agreements and Equity Sales — Sep 30, 2025 Risk: medium
MAIA Biotechnology, Inc. filed an 8-K on September 30, 2025, reporting on several events that occurred on September 29, 2025. These include entering into a mate
MAIA Biotechnology Files 8-K — Sep 24, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on September 24, 2025, reporting other events and financial statements. The company, incorporated in Delaware, is based in
MAIA Biotechnology Files 8-K on Material Agreement — Sep 18, 2025 Risk: medium
On September 18, 2025, MAIA Biotechnology, Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equi
MAIA Biotechnology Files 8-K — Sep 12, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on September 12, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its pri
MAIA Biotechnology Files 8-K — Sep 11, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on September 11, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain speci
MAIA Biotechnology to Acquire Private Company — Sep 8, 2025 Risk: medium
MAIA Biotechnology, Inc. announced on September 7, 2025, that it has entered into a definitive agreement to acquire all outstanding equity interests of a privat
MAIA Biotechnology Files 8-K — Aug 13, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on August 13, 2025, reporting other events and financial statements. The filing does not contain specific financial figure
MAIA Biotechnology Files 8-K — Jul 28, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on July 28, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific d
MAIA Biotechnology Files 8-K — Jul 17, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on July 17, 2025, reporting other events and financial statements. The filing does not contain specific details about the
MAIA Biotechnology Files 8-K — Jul 9, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on July 9, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing details the company's incorp
MAIA Biotechnology Files 8-K with Key Agreements and Sales — Jun 26, 2025 Risk: medium
On June 24, 2025, MAIA Biotechnology, Inc. filed an 8-K report detailing several key events. The company entered into a material definitive agreement, reported
MAIA Biotechnology Files 8-K — Jun 24, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on June 24, 2025, reporting other events and financial statements. The filing does not contain specific details about the
MAIA Biotechnology Files 8-K — Jun 18, 2025 Risk: low
On June 18, 2025, MAIA Biotechnology, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating
MAIA Biotechnology Files 8-K on Material Agreement — Jun 17, 2025 Risk: medium
On June 17, 2025, MAIA Biotechnology, Inc. filed an 8-K report detailing a material definitive agreement. The filing also covers unregistered sales of equity se
MAIA Biotechnology Files 8-K — Jun 5, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on June 5, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific de
8-K Filing — Jun 2, 2025
MAIA Biotechnology Files 8-K: Material Agreement, Equity Sales — May 28, 2025 Risk: medium
On May 27, 2025, MAIA Biotechnology, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
MAIA Biotechnology Files 8-K for Bylaw Amendments — May 23, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on May 23, 2025, reporting events as of May 22, 2025. The filing primarily concerns amendments to its articles of incorpor
MAIA Biotechnology Files 8-K — May 22, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on May 22, 2025, reporting on matters submitted to a vote of security holders, other events, and financial statements/exhi
MAIA Biotechnology Files 8-K: Material Agreement & Equity Sales — May 6, 2025 Risk: medium
On May 5, 2025, MAIA Biotechnology, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
8-K Filing — Apr 22, 2025
MAIA Biotechnology Files 8-K — Apr 1, 2025 Risk: low
On April 1, 2025, MAIA Biotechnology, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating
MAIA Biotechnology Files 8-K — Mar 28, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on March 28, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
MAIA Biotechnology Files 8-K — Mar 26, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on March 26, 2025, reporting other events and financial statements. The company, incorporated in Delaware with its princip
MAIA Biotechnology Files 8-K — Mar 21, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on March 21, 2025, reporting other events and financial statements. The filing details the company's incorporation in Dela
MAIA Biotechnology Files 8-K — Mar 19, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on March 19, 2025, reporting other events and financial statements. The filing details the company's incorporation in Dela
MAIA Biotechnology Files 8-K — Feb 27, 2025 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on February 27, 2025, reporting other events and financial statements. The filing details the company's corporate structur
MAIA Biotechnology Files 8-K: Material Agreement, Equity Sales — Feb 25, 2025 Risk: medium
MAIA Biotechnology, Inc. announced on February 24, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales o
MAIA Biotechnology Files 8-K: Material Agreement & Equity Sales — Feb 19, 2025 Risk: medium
MAIA Biotechnology, Inc. announced on February 18, 2025, that it entered into a material definitive agreement. The company also reported on unregistered sales o
MAIA Biotechnology Files 8-K on Director/Officer Changes — Feb 6, 2025 Risk: medium
MAIA Biotechnology, Inc. filed an 8-K on February 6, 2025, reporting on the departure of directors, election of new directors, appointment of officers, and comp
MAIA Bio Presents at J.P. Morgan Healthcare Conference — Feb 5, 2025 Risk: medium
On February 4, 2025, MAIA Biotechnology, Inc. announced its participation in the 36th Annual J.P. Morgan Healthcare Conference. The company presented its pipeli
MAIA Biotechnology Files 8-K — Dec 23, 2024 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on December 23, 2024, reporting other events and financial statements/exhibits. The filing does not contain specific finan
MAIA Biotechnology Files 8-K — Dec 20, 2024 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on December 20, 2024, reporting events as of December 16, 2024. The filing pertains to "Other Events" and "Financial State
MAIA Biotechnology Files 8-K: Material Agreement & Equity Sales — Dec 10, 2024 Risk: medium
MAIA Biotechnology, Inc. announced on December 9, 2024, that it entered into a material definitive agreement. The company also reported on unregistered sales of
8-K Filing — Nov 8, 2024
MAIA Biotechnology Files 8-K — Nov 5, 2024 Risk: low
MAIA Biotechnology, Inc. filed an 8-K on November 5, 2024, reporting other events and financial statements. The filing details the company's incorporation in De
MAIA Biotechnology Files 8-K: Material Agreement & Equity Sales — Oct 29, 2024 Risk: medium
MAIA Biotechnology, Inc. announced on October 28, 2024, that it entered into a material definitive agreement. The company also reported on unregistered sales of

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX